Literature DB >> 11923072

Intracellular signal transduction of cells in response to carcinogenic metals.

Fei Chen1, Xianglin Shi.   

Abstract

Epidemiological and animal studies suggest that several metals and metal-containing compounds are potent mutagens and carcinogens. These metals include chromium, arsenic, vanadium, nickel, and others. During the last two decades, chemical and cellular studies have contributed enormously to our understanding of the mechanisms of metal-induced pathophysiological processes. Although each of these metals is unique in its mechanism of action, some common signaling molecules, such as reactive oxygen species (ROS), may be shared by many of the carcinogenic metals. New techniques are now available to reveal the mechanisms of carcinogenesis in precise molecular terms. In this review, we focused our attentions on carcinogenic metal-induced signal transduction pathways leading to the activation of NF-kappaB, cell apoptosis and cell cycle progression, three crucial steps or events involved in the transformation and carcinogenesis. This review summarizes current knowledge and our recent studies concerning intracellular signal transduction pathways initiated by carcinogenic metals and the cross-talk that occurs among these pathways in cells in response to metals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923072     DOI: 10.1016/s1040-8428(01)00211-6

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  21 in total

1.  ERKs activation and calcium signaling are both required for VEGF induction by vanadium in mouse epidermal Cl41 cells.

Authors:  Jingxia Li; Qiangsong Tong; Xianglin Shi; Max Costa; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

2.  Altered iron homeostasis involvement in arsenite-mediated cell transformation.

Authors:  Jing Wu; Jonathan Eckard; Haobin Chen; Max Costa; Krystyna Frenkel; Xi Huang
Journal:  Free Radic Biol Med       Date:  2005-11-08       Impact factor: 7.376

3.  Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenic-transformed epithelial cells.

Authors:  Qingshan Chang; Jingju Pan; Xing Wang; Zhuo Zhang; Fei Chen; Xianglin Shi
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

4.  Nickel induces oxidative burst, NF-κB activation and interleukin-8 production in human neutrophils.

Authors:  Marisa Freitas; Ana Gomes; Graça Porto; Eduarda Fernandes
Journal:  J Biol Inorg Chem       Date:  2010-07-15       Impact factor: 3.358

5.  Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.

Authors:  Erika B Dugo; Clement G Yedjou; Jacqueline J Stevens; Paul B Tchounwou
Journal:  Ann Clin Pathol       Date:  2017-01-04

6.  JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic.

Authors:  Bailing Chen; Jia Liu; Qingshan Chang; Kevin Beezhold; Yongju Lu; Fei Chen
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

Review 7.  Metal-induced toxicity, carcinogenesis, mechanisms and cellular responses.

Authors:  Stephen S Leonard; Jacquelyn J Bower; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

8.  Oxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and prevention.

Authors:  Lingzhi Li; Fei Chen
Journal:  Curr Pharmacol Rep       Date:  2016-01-23

9.  The effect of PM10 on human lung fibroblasts.

Authors:  Df Alley; S Langley-Turnbaugh; Nr Gordon; Jp Wise; G Van Epps; A Jalbert
Journal:  Toxicol Ind Health       Date:  2009-03       Impact factor: 2.273

10.  Involvement of histone hypoacetylation in Ni2+-induced bcl- 2 down-regulation and human hepatoma cell apoptosis.

Authors:  Jiuhong Kang; Dawei Zhang; Jie Chen; Changjun Lin; Qing Liu
Journal:  J Biol Inorg Chem       Date:  2004-07-03       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.